Anchor Investment Management LLC grew its position in AMETEK, Inc. (NYSE:AME – Free Report) by 366.1% in the third quarter, HoldingsChannel reports. The institutional investor owned 261 shares of the technology company’s stock after acquiring an additional 205 shares during the period. Anchor Investment Management LLC’s holdings in AMETEK were worth $45,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp grew its position in AMETEK by 34.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,602,753 shares of the technology company’s stock valued at $600,615,000 after acquiring an additional 926,657 shares in the last quarter. EdgePoint Investment Group Inc. grew its holdings in shares of AMETEK by 87.9% in the third quarter. EdgePoint Investment Group Inc. now owns 1,964,236 shares of the technology company’s stock valued at $337,279,000 after purchasing an additional 918,737 shares in the last quarter. Meridiem Investment Management Ltd. purchased a new stake in AMETEK during the 3rd quarter worth approximately $130,579,000. Principal Financial Group Inc. lifted its holdings in AMETEK by 72.0% during the 3rd quarter. Principal Financial Group Inc. now owns 1,680,309 shares of the technology company’s stock worth $288,526,000 after buying an additional 703,501 shares in the last quarter. Finally, D1 Capital Partners L.P. purchased a new position in AMETEK in the 3rd quarter valued at approximately $79,782,000. Institutional investors and hedge funds own 87.43% of the company’s stock.
AMETEK Stock Down 0.6 %
Shares of NYSE:AME opened at $187.38 on Friday. AMETEK, Inc. has a twelve month low of $149.03 and a twelve month high of $198.33. The company has a market capitalization of $43.34 billion, a PE ratio of 32.64, a P/E/G ratio of 3.08 and a beta of 1.15. The company has a current ratio of 1.39, a quick ratio of 0.84 and a debt-to-equity ratio of 0.18. The firm has a 50 day simple moving average of $183.21 and a 200-day simple moving average of $173.08.
AMETEK Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 0.60%. The ex-dividend date of this dividend is Friday, December 6th. AMETEK’s payout ratio is currently 19.51%.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on AME. StockNews.com upgraded AMETEK from a “hold” rating to a “buy” rating in a research note on Wednesday, December 4th. Mizuho lifted their price objective on AMETEK from $190.00 to $200.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. Robert W. Baird upped their target price on shares of AMETEK from $166.00 to $186.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. KeyCorp lifted their price target on shares of AMETEK from $205.00 to $215.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. Finally, Wolfe Research upgraded shares of AMETEK to a “hold” rating in a report on Wednesday, September 18th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $199.29.
Read Our Latest Stock Report on AME
Insider Buying and Selling at AMETEK
In other AMETEK news, insider Tony J. Ciampitti sold 16,210 shares of AMETEK stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $197.01, for a total value of $3,193,532.10. Following the transaction, the insider now directly owns 49,490 shares in the company, valued at approximately $9,750,024.90. This trade represents a 24.67 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider David F. Hermance sold 6,243 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $190.99, for a total value of $1,192,350.57. Following the sale, the insider now owns 36,731 shares of the company’s stock, valued at $7,015,253.69. This trade represents a 14.53 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 30,660 shares of company stock worth $5,958,141. 0.61% of the stock is owned by company insiders.
About AMETEK
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
See Also
- Five stocks we like better than AMETEK
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Stock Analyst Ratings and Canadian Analyst Ratings
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Use Stock Screeners to Find Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.